Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Striving to become more patient-centric?

    August 25, 2020 |  

    Explore more with OPEN Health

    Patients are increasingly involved in their healthcare decisions. They have become empowered and informed data-driven advocates for their own health. We are currently at a tipping point in the industry as regulatory bodies and patient advocacy groups have come together to reinforce the importance of the role of patients in the drug development process.

    Why now?

    • Patient engagement tools have evolved considerably
    • There is an increased role of patients in regulatory and health technology decision making
    • Healthcare players who are unable or unwilling to deepen collaborations in the industry may find it difficult, if not impossible, to participate in a future patient-driven healthcare system

    But how does a patient-centric approach evolve from a one-off engagement tactic to a fully integrated, company-wide practice?

    Join us and take an interactive tour through today’s modern approach to patient-centricity. We will show how patient-centricity can be integrated into all phases of development and commercialization and show examples of how to achieve patient buy-in and ensure the patient voice is represented in your study outcomes.

    Start Your Journey

    In this interactive journey, you will:

    • Learn about the value of a patient-centric approach
    • Explore areas to focus on at different phases of the product life cycle
    • See real-life case studies of how a patient-centric approach can be used in therapeutic areas such as oncology, rare disease and advanced therapies
    • Find out how to take your first step to a patient-centric approach
    • Meet our team of experts and what drives them

    Pink divider

    Pharmerit – an OPEN Health Company has been at the forefront of the evolution of patient-centricity. We have seen the positive impact of engaging patients throughout the product lifecycle. We believe it is important to include patient-centricity in every project we undertake, combining expertise with outcomes to see the impact of co-creation.

    This content was provided by OPEN Health

    Company Details

    OPEN Health

    OPEN Health

    Email
    Website

     Latest Content from  OPEN Health 

    The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

    The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

    OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

    OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

    Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

    Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

    Embracing the Patient Voice Within Publications

    This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from...

    Navigating the nocebo effect through patient engagement is the key to setting patients up for success

    If you're interested in delving deeper into this topic and understanding how patient engagement can effectively navigate the nocebo effect, we invite you to explore our latest whitepaper.

    OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office

    OPEN Health, a global provider of consultancy, HEOR and market access, and scientific communications services, announced a new team of experts will lead its HEOR & Market Access Scientific Office.

    OPEN Health Appoints Richard Jones as President for Evidence & Access

    OPEN Health is pleased to announce the appointment of Richard Jones as President for Evidence & Access.

    Drive, Discover, Dive_OPEN Health

    Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.

    Novel Oncology Therapies Require Innovative Methods in Oncology Modeling

    Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.

    The CM Group rebrands to OPEN Health

    Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding...